Absci and deep learning’s quest for the perfect protein

Absci and deep learning’s quest for the perfect protein

The company has used one giant A.I. representation of proteins to broaden the search for novel biologics and hopes to do everything in silico someday.   Written by Tiernan Ray, Contributing Writer on January 7, 2022 The breakthrough of CRISPR technology in the...
Absci and deep learning’s quest for the perfect protein

Absci Announces Research Collaboration with Merck

Collaboration to leverage Absci’s Deep Learning-Enabled Drug Creation™ and Bionic Protein™ technologies VANCOUVER, Wash., Jan. 07, 2022 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and...
Xandar Kardian raises $10M for its vital signs radar

Xandar Kardian raises $10M for its vital signs radar

Contactless health monitoring technology developer Xandar Kardian announced today that it closed a $10 million Series A financing round.   Toronto-based Xandar Kardian’s Series A round was led by Phoenix Venture Partners, Portfolia Active Aging & Longevity...
FibreCoat closes first financing round

FibreCoat closes first financing round

(Aachen) 17.11.2021—FibreCoat GmbH, an innovative composite materials spin-off from the Institut für Textiltechnik (ITA) of RWTH Aachen University, announces it closed a $3 million Series A round with Goose Capital, Phoenix Venture Partners, b.value AG, NOVA by...
EUSA, Shire veteran joins Woburn startup as CEO

EUSA, Shire veteran joins Woburn startup as CEO

ReForm Biologics, the Woburn startup that earlier this summer tapped former Genzyme CFO and Massachusetts Biotechnology Council co-founder Jim Sherblom as executive chairman, has netted another big fish in Jeffrey Hackman. Hackman joins the company as CEO after nearly...